Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59,885 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-Dose immunoglobulin Intervention as an effective and simple strategy for donor specific Anti-HLA antibody desensitization in haploidentical transplant.
Zhu J, Wang Q, Liu Y, Dong Y, Liang Z, Yin Y, Liu W, Xu W, Sun Y, Wang B, Wang Q, Wang Q, Han N, Ren H, Li Y. Zhu J, et al. Among authors: liu y, liu w. Int Immunopharmacol. 2023 Jul;120:110299. doi: 10.1016/j.intimp.2023.110299. Epub 2023 May 16. Int Immunopharmacol. 2023. PMID: 37201405 Free article.
Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial.
Chen Y, Xu Y, Chi Y, Sun T, Gao Y, Dou X, Han Z, Xue F, Li H, Liu W, Liu X, Dong H, Fu R, Ju M, Dai X, Wang W, Ma Y, Song Z, Gu J, Gong W, Yang R, Zhang L. Chen Y, et al. Among authors: liu x, liu w. Signal Transduct Target Ther. 2024 Apr 23;9(1):102. doi: 10.1038/s41392-024-01793-5. Signal Transduct Target Ther. 2024. PMID: 38653983 Free PMC article. Clinical Trial.
59,885 results
You have reached the last available page of results. Please see the User Guide for more information.